CTX-712
Product Specifications
UNSPSC Description
CTX-712 is an orally effective CLK 2 inhibitor, with an IC50 of 1.4 nM, showing anti-tumor activity[1][2].
Target Antigen
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ctx-712.html
Solubility
DMSO : 25 mg/mL (ultrasonic)
Smiles
CC1=NC2=NC=C(C3=C4C(OC)=NC=NN4C=C3)C=C2N1CC5=NN=C([C@H](F)C)O5
Molecular Weight
408.39
References & Citations
[1]Akinori Yoda, et al. CTX-712, a Novel Clk Inhibitor Targeting Myeloid Neoplasms with SRSF2 Mutation. Blood. (2021) 205–206 |[2]Zhen Qin, et al. Development of Cdc2-like Kinase 2 Inhibitors: Achievements and Future Directions. J Med Chem. 2021 Sep 23;64(18):13191-13211.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-144875/CTX-712-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-144875/CTX-712-SDS-MedChemExpress.pdf
Clinical Information
Phase 2
CAS Number
2144751-78-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
H00004929-Q01-10ug 10 µg
Recombinant Human Nurr1/NGFI-B beta/NR4A2 Protein - (Dry Ice)
Ask
View Details 
MBS6465083-01 0.1 mL
Bcl-w, BH3 Domain (Bcl2-like Protein 2, BCL2L2, Apoptosis Regulator Bcl-W, BCLW, KIAA0271) (MaxLight 650)
Ask
View Details 
MBS6465083-02 5x 0.1 mL
Bcl-w, BH3 Domain (Bcl2-like Protein 2, BCL2L2, Apoptosis Regulator Bcl-W, BCLW, KIAA0271) (MaxLight 650)
Ask
View Details